279 related articles for article (PubMed ID: 32887653)
21. Berberine versus placebo for the prevention of recurrence of colorectal adenoma: a multicentre, double-blinded, randomised controlled study.
Chen YX; Gao QY; Zou TH; Wang BM; Liu SD; Sheng JQ; Ren JL; Zou XP; Liu ZJ; Song YY; Xiao B; Sun XM; Dou XT; Cao HL; Yang XN; Li N; Kang Q; Zhu W; Xu HZ; Chen HM; Cao XC; Fang JY
Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):267-275. PubMed ID: 31926918
[TBL] [Abstract][Full Text] [Related]
22. APACC, a French prospective study on aspirin efficacy in reducing colorectal adenoma recurrence: design and baseline findings.
Benamouzig R; Yoon H; Little J; Martin A; Couturier D; Deyra J; Coste T; Chaussade S;
Eur J Cancer Prev; 2001 Aug; 10(4):327-35. PubMed ID: 11535875
[TBL] [Abstract][Full Text] [Related]
23. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
Baron JA; Sandler RS; Bresalier RS; Quan H; Riddell R; Lanas A; Bolognese JA; Oxenius B; Horgan K; Loftus S; Morton DG;
Gastroenterology; 2006 Dec; 131(6):1674-82. PubMed ID: 17087947
[TBL] [Abstract][Full Text] [Related]
24. Aspirin in the chemoprevention of colorectal neoplasia: an overview.
Chan AT; Arber N; Burn J; Chia WK; Elwood P; Hull MA; Logan RF; Rothwell PM; Schrör K; Baron JA
Cancer Prev Res (Phila); 2012 Feb; 5(2):164-78. PubMed ID: 22084361
[TBL] [Abstract][Full Text] [Related]
25. Quality of Colonoscopy Is Associated With Adenoma Detection and Postcolonoscopy Colorectal Cancer Prevention in Lynch Syndrome.
Sánchez A; Roos VH; Navarro M; Pineda M; Caballol B; Moreno L; Carballal S; Rodríguez-Alonso L; Ramon Y Cajal T; Llort G; Piñol V; López-Fernández A; Salces I; Picó MD; Rivas L; Bujanda L; Garzon M; Pizarro A; Martinez de Castro E; López-Arias MJ; Poves C; Garau C; Rodriguez-Alcalde D; Herraiz M; Alvarez-Urrutia C; Dacal A; Carrillo-Palau M; Cid L; Ponce M; Barreiro-Alonso E; Saperas E; Aguirre E; Romero C; Bastiaansen B; Gonzalez-Acosta M; Morales-Romero B; Ocaña T; Rivero-Sánchez L; Jung G; Bessa X; Cubiella J; Jover R; Rodríguez-Moranta F; Balmaña J; Brunet J; Castells A; Dekker E; Capella G; Serra-Burriel M; Moreira L; Pellise M; Balaguer F
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):611-621.e9. PubMed ID: 33157315
[TBL] [Abstract][Full Text] [Related]
26. ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial.
Drew DA; Chin SM; Gilpin KK; Parziale M; Pond E; Schuck MM; Stewart K; Flagg M; Rawlings CA; Backman V; Carolan PJ; Chung DC; Colizzo FP; Freedman M; Gala M; Garber JJ; Huttenhower C; Kedrin D; Khalili H; Kwon DS; Markowitz SD; Milne GL; Nishioka NS; Richter JM; Roy HK; Staller K; Wang M; Chan AT
Trials; 2017 Feb; 18(1):50. PubMed ID: 28143522
[TBL] [Abstract][Full Text] [Related]
27. Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial.
Ishikawa H; Wakabayashi K; Suzuki S; Mutoh M; Hirata K; Nakamura T; Takeyama I; Kawano A; Gondo N; Abe T; Tokudome S; Goto C; Matsuura N; Sakai T
Cancer Med; 2013 Feb; 2(1):50-6. PubMed ID: 24133627
[TBL] [Abstract][Full Text] [Related]
28. Aspirin as secondary prevention in colorectal cancer liver metastasis (ASAC trial): study protocol for a multicentre randomized placebo-controlled trial.
Yaqub S; Bjørnbeth BA; Angelsen JH; Fristrup CW; Grønbech JE; Hemmingsson O; Isaksson B; Juel IS; Larsen PN; Lindell G; Mortensen FV; Mortensen KE; Rizell M; Sandström P; Sandvik OM; Sparrelid E; Taflin H; Taskén K;
Trials; 2021 Sep; 22(1):642. PubMed ID: 34544470
[TBL] [Abstract][Full Text] [Related]
29. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial.
Meyskens FL; McLaren CE; Pelot D; Fujikawa-Brooks S; Carpenter PM; Hawk E; Kelloff G; Lawson MJ; Kidao J; McCracken J; Albers CG; Ahnen DJ; Turgeon DK; Goldschmid S; Lance P; Hagedorn CH; Gillen DL; Gerner EW
Cancer Prev Res (Phila); 2008 Jun; 1(1):32-8. PubMed ID: 18841250
[TBL] [Abstract][Full Text] [Related]
30. Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population.
Stingl JC; Ettrich T; Muche R; Wiedom M; Brockmöller J; Seeringer A; Seufferlein T
BMC Cancer; 2011 Aug; 11():360. PubMed ID: 21851602
[TBL] [Abstract][Full Text] [Related]
31. Daily aspirin reduces colorectal cancer incidence in patients with Lynch syndrome.
Barton MK
CA Cancer J Clin; 2012; 62(3):143-4. PubMed ID: 22411104
[No Abstract] [Full Text] [Related]
32. Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up.
Mathers JC; Elliott F; Macrae F; Mecklin JP; Möslein G; McRonald FE; Bertario L; Evans DG; Gerdes AM; Ho JWC; Lindblom A; Morrison PJ; Rashbass J; Ramesar RS; Seppälä TT; Thomas HJW; Sheth HJ; Pylvänäinen K; Reed L; Borthwick GM; Bishop DT; Burn J;
Cancer Prev Res (Phila); 2022 Sep; 15(9):623-634. PubMed ID: 35878732
[TBL] [Abstract][Full Text] [Related]
33. Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial.
Higurashi T; Hosono K; Endo H; Takahashi H; Iida H; Uchiyama T; Ezuka A; Uchiyama S; Yamada E; Ohkubo H; Sakai E; Maeda S; Morita S; Natsumeda Y; Nagase H; Nakajima A
BMC Cancer; 2012 Sep; 12():413. PubMed ID: 22992267
[TBL] [Abstract][Full Text] [Related]
34. Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial.
Benamouzig R; Uzzan B; Deyra J; Martin A; Girard B; Little J; Chaussade S;
Gut; 2012 Feb; 61(2):255-61. PubMed ID: 21890814
[TBL] [Abstract][Full Text] [Related]
35. Cyclooxygenase as a target for colorectal cancer chemoprevention.
Moreira L; Castells A
Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
[TBL] [Abstract][Full Text] [Related]
36. Adenoma recurrences after resection of colorectal carcinoma: results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study.
Chu DZ; Chansky K; Alberts DS; Meyskens FL; Fenoglio-Preiser CM; Rivkin SE; Mills GM; Giguere JK; Goodman GE; Abbruzzese JL; Lippman SM
Ann Surg Oncol; 2003 Oct; 10(8):870-5. PubMed ID: 14527904
[TBL] [Abstract][Full Text] [Related]
37. The "unnatural" history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillance.
Ahadova A; Seppälä TT; Engel C; Gallon R; Burn J; Holinski-Feder E; Steinke-Lange V; Möslein G; Nielsen M; Ten Broeke SW; Laghi L; Dominguez-Valentin M; Capella G; Macrae F; Scott R; Hüneburg R; Nattermann J; Hoffmeister M; Brenner H; Bläker H; von Knebel Doeberitz M; Sampson JR; Vasen H; Mecklin JP; Møller P; Kloor M
Int J Cancer; 2021 Feb; 148(4):800-811. PubMed ID: 32683684
[TBL] [Abstract][Full Text] [Related]
38. Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials.
Veettil SK; Lim KG; Ching SM; Saokaew S; Phisalprapa P; Chaiyakunapruk N
BMC Cancer; 2017 Nov; 17(1):763. PubMed ID: 29137605
[TBL] [Abstract][Full Text] [Related]
39. Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population.
Cenin DR; Naber SK; Lansdorp-Vogelaar I; Jenkins MA; Buchanan DD; Preen DB; Ee HC; O'Leary P
J Gastroenterol Hepatol; 2018 Oct; 33(10):1737-1744. PubMed ID: 29645364
[TBL] [Abstract][Full Text] [Related]
40. Colonoscopy findings in high-risk individuals compared to an average-risk control population.
Forsberg A; Kjellström L; Andreasson A; Jaramillo E; Rubio CA; Björck E; Agréus L; Talley NJ; Lindblom A
Scand J Gastroenterol; 2015 Jul; 50(7):866-74. PubMed ID: 25762374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
